Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Pinheiro

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Drug Safety|May 23, 2018
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General PracticeJim Slattery, Daniel Morales, Luis Pinheiro, et al.
Nature Reviews. Drug Discovery|November 21, 2022
Artificial intelligence in European medicines regulationPhilip A Hines, Ralf Herold, Luis Pinheiro, et al.
Clinical Drug Investigation|August 26, 2018
Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based StudyDaniel R Morales, Jim Slattery, Luis Pinheiro, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilanceLuis Pinheiro, Kevin Blake, Justina Januskiene, et al.
Journal of Chemical Information and Modeling|May 23, 2012
A Bayesian approach to in silico blood-brain barrier penetration modelingInes Filipa Martins, Ana L Teixeira, Luis Pinheiro, et al.
JAMA Neurology|April 30, 2019
Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate TherapyDaniel Morales, Alexandra Pacurariu, Jim Slattery, et al.
Clinical Drug Investigation|February 7, 2019
Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Jim Slattery, Alexandra Pacurariu, et al.
Clinical Drug Investigation|November 23, 2018
Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Jim Slattery, Alexandra Pacurariu, et al.
British Journal of Clinical Pharmacology|April 28, 2022
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practiceJim Slattery, Chantal Quinten, Gianmario Candore, et al.
Archivos Argentinos De Pediatria|May 15, 2010
[Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis]Hilda Giugno, Claudio Castaños, Alberto Lubatti, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Drug Safety|May 23, 2018
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General PracticeJim Slattery, Daniel Morales, Luis Pinheiro, et al.
Nature Reviews. Drug Discovery|November 21, 2022
Artificial intelligence in European medicines regulationPhilip A Hines, Ralf Herold, Luis Pinheiro, et al.
Clinical Drug Investigation|August 26, 2018
Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based StudyDaniel R Morales, Jim Slattery, Luis Pinheiro, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilanceLuis Pinheiro, Kevin Blake, Justina Januskiene, et al.
Journal of Chemical Information and Modeling|May 23, 2012
A Bayesian approach to in silico blood-brain barrier penetration modelingInes Filipa Martins, Ana L Teixeira, Luis Pinheiro, et al.
JAMA Neurology|April 30, 2019
Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate TherapyDaniel Morales, Alexandra Pacurariu, Jim Slattery, et al.
Clinical Drug Investigation|February 7, 2019
Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Jim Slattery, Alexandra Pacurariu, et al.
Clinical Drug Investigation|November 23, 2018
Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Jim Slattery, Alexandra Pacurariu, et al.
British Journal of Clinical Pharmacology|April 28, 2022
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practiceJim Slattery, Chantal Quinten, Gianmario Candore, et al.
Archivos Argentinos De Pediatria|May 15, 2010
[Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis]Hilda Giugno, Claudio Castaños, Alberto Lubatti, et al.
Pageof 2